Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marrow Aspirate Concentrate vs Triamcinolone for Hip Osteoarthritis
NCT04990128Phase 3Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous bone marrow cell concentrate in hip osteoarthritis (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Western Ontario McMaster Universities Arthritis Index at 12 months. Started Aug 2026; status: recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT04990128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04990128.